Navigation Links
VacChina 2011 - Bridging the China Vaccine Industry with the World Class Biotechnologies
Date:8/18/2011

SHANGHAI, Aug. 18, 2011 /PRNewswire-Asia/ -- VacChina 2011 -- China's largest vaccine meeting -- welcomes world class biotechs and pharmas to discuss the opportunities of development of novel vaccine R&D and manufacturing technologies in China.

The World Health Organization (WHO) announced on March 1, 2011, that the national regulatory authority of China -- the State Food and Drug Administration (SFDA), along with affiliated institutions -- now meets WHO indicators for a functional vaccine regulatory system. This means that Chinese-made vaccines are now eligible to apply for WHO pre-qualification. On the same day as this WHO announcement, the China SFDA also adopted a new Good Manufacturing Practice code. The new code puts in place stricter requirements for vaccine production, in line with international standards, in order to ensure quality.

The announcement will motivate domestic manufacturers to strengthen vaccine development partnerships with international organizations at broader and more strategic levels. More government funding will also pour into companies working toward the goal of WHO pre-qualification. Furthermore, a new interest in vaccine technology will encourage Chinese scientists who are now working overseas to return to the country in order to leverage this opportunity.

Supported by BayHelix and hosted by Global Leaders Institute, world vaccine industry leaders will convene at VacChina 2011 on Nov 29 and 30 in Shanghai. The two-day executive summit will explore the major partnering opportunities in the vaccine industry in China. The goal of the summit is to bridge the China vaccine industry with the world class biotechnologies in terms of vaccine R&D and production.

Key issues to be addressed:

  • The requirements or the process of WHO pre-qualification, UNICEF procurement programs, or GAVI's working mechanisms
  • How to align China SFDA's regulatory pathways and domestic clinical trials with international standards and requirements
  • What do new Chinese Good Manufacturing Practice (GMP) standards and WHO approval for China's vaccine regulatory system mean for China's vaccine industry? Now that Chinese vaccine manufacturers can apply for WHO prequalification, will China take on a bigger role as a global vaccine supplier? Should we expect China to take a larger role developing novel vaccines?
  • What kind of assistance do SFDA, CDC and Chinese manufacturers need from international partners (WHO, UNICEF, PATH, etc) to improve and meet international standards? How will China respond to international concerns about quality and safety of Chinese vaccines?
  • Novel approaches to cell culture to accelerate development and quality control
  • How to improve cost and time to the clinic and ensure product quality through downstream processing
  • Strategies to accelerate vaccine development process with the latest expression and characterization technologies

For more information, please visit vac.globaleaders.com or contact:

Daniel Chen
Tel: +86-21-3251-6046 or email: daniel.chen@globaleaders.com


'/>"/>
SOURCE Global Leaders Institute
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Vaccine Leaders All Over the World Talking About China Vaccine Opportunities at VacChina 2010 -- the No.1 China Focused Vaccine Partnering Forum
2. VacChina 2010 - A Premium Event to Define the Vaccine Industry in Asia
3. TRIA Beauty Leading the Charge in Bridging Gap Between Science and Skin Health
4. PAREXEL Achieves 100th Asian Ethnobridging Study Milestone
5. Clinical Update - Debio 9902 SR (ZT-1) for Alzheimer Patients Debiopharm Starts Tablet Formulations Bridging Study under IND
6. New Company Starts, Bridging the Development Gap in the Discovery of Cancer Drugs
7. China Contract Research Organization (CRO) Industry Report, 2010-2011
8. Abbott Expanding Manufacturing Capacity in China to Meet Demands of Fast-Growing Nutrition Market
9. China Nuvo Solar Target Acquisition SurgLine Updates OptiMedical Corp.s Sales Forecast in Excess of $10,000,000
10. China Medical Technologies Reports First Fiscal Quarter Financial Results
11. Chairman of Global Guide to COPD Diagnosis Committee Visited West China Hospital
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... 20, 2017 ResMed (NYSE: RMD ), BMC ... Winter Haven, Florida ) today announced they have agreed on ... 3B will be permitted to sell their existing products in exchange ... settlement payment to 3B to close the Florida ... an admission of liability or wrongdoing by any party. ...
(Date:1/21/2017)... 20, 2017  Today, during a plenary ... Pathways in Immunology, Growth Disorders and Cancer," ... INFI ) presented preclinical data for ... selectively inhibits phosphoinositide-3-kinase-gamma (PI3K-gamma). Preclinical data showed ... resistance to checkpoint inhibition by remodeling the ...
(Date:1/20/2017)... Research and Markets has announced the addition of the ... Creatinine, Electrolyte Testing, HbA1c Testing, Comprehensive Metabolic Panel, Liver Panel, Renal ... report to their offering. ... The global clinical laboratory testing market is expected ... innovative solutions on the grounds of maximum efficiency and minimum error ...
Breaking Medicine Technology:
(Date:1/21/2017)... ... January 21, 2017 , ... Northern California Medical ... recently joined their multi-specialty medical group. The dermatology practice provides general dermatologic treatment, ... excited to add this excellent dermatology practice to our group’s medical services,” explains ...
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... Spectrum Aquatics Launches New ADA Portable Motion ... deck space. Since the lift is mounted on wheels, it can be wheeled out of ... down kit, to fasten to the deck. "We have transformed the feedback from customers into ...
(Date:1/20/2017)... Boca Raton, FL (PRWEB) , ... January 20, 2017 , ... ... supplement development, announced it attended the January ECRM trade show to continue the marketing ... technologically advanced vitamin C supplement, known for providing 400 percent better absorption than traditional ...
(Date:1/20/2017)... ... ... International Protein, a company based out of Australia that focuses on developing ... trade show in Hilton Head, SC. , International Protein was founded by Christine ... of products that would elevate her fitness regime. At this ECRM trade show, Envall ...
(Date:1/20/2017)... ... , ... “Mary Magdalene: Grace is Greater than Sin”: a unique and ... Christ firsthand. “Mary Magdalene: Grace is Greater than Sin” is the creation of published ... with countless women who had little knowledge of the female characters portrayed in the ...
Breaking Medicine News(10 mins):